1054 related articles for article (PubMed ID: 23913554)
1. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
[TBL] [Abstract][Full Text] [Related]
2. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
[TBL] [Abstract][Full Text] [Related]
3. CD8
Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
[TBL] [Abstract][Full Text] [Related]
4. Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.
Lechien JR; Seminerio I; Descamps G; Mat Q; Mouawad F; Hans S; Julieron M; Dequanter D; Vanderhaegen T; Journe F; Saussez S
Cells; 2019 Sep; 8(9):. PubMed ID: 31510065
[TBL] [Abstract][Full Text] [Related]
5. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
7. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
[TBL] [Abstract][Full Text] [Related]
9. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.
Zhang M; Kumar B; Piao L; Xie X; Schmitt A; Arradaza N; Cippola M; Old M; Agrawal A; Ozer E; Schuller DE; Teknos TN; Pan Q
Cancer; 2014 Apr; 120(7):992-1001. PubMed ID: 24382806
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
[TBL] [Abstract][Full Text] [Related]
12. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.
Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES
Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388
[TBL] [Abstract][Full Text] [Related]
13. Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
Mazul AL; Taylor JM; Divaris K; Weissler MC; Brennan P; Anantharaman D; Abedi-Ardekani B; Olshan AF; Zevallos JP
Cancer; 2017 Jan; 123(1):71-80. PubMed ID: 27571516
[TBL] [Abstract][Full Text] [Related]
14. Vaccination Expectations in HNSCC.
Syrjänen S; Rautava J
Recent Results Cancer Res; 2017; 206():257-267. PubMed ID: 27699546
[TBL] [Abstract][Full Text] [Related]
15. [Immune System in Patients with Head and Neck Carcinoma].
Partlová S; Bouček J; Kloudová K; Zábrodský M; Špíšek R; Fialová A
Klin Onkol; 2015; 28 Suppl 4():4S86-94. PubMed ID: 26647896
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
Dalianis T
Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
[TBL] [Abstract][Full Text] [Related]
17. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
18. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
19. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.
Speel EJ
Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529
[TBL] [Abstract][Full Text] [Related]
20. Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy.
Al-Taei S; Banner R; Powell N; Evans M; Palaniappan N; Tabi Z; Man S
Cancer Immunol Immunother; 2013 Dec; 62(12):1821-30. PubMed ID: 24146146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]